Unprecedented exploration generates most comprehensive map of cancer genomes to date
An international team has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
Published in Nature, more...
Planning for an ebola vaccine
Health organisations have started to plan a campaign of use for a vaccine against the deadly ebola disease.
The work is being done by the World Health Organization (WHO), its partners and affected countries after...
Ebola breakthrough is announced
Researchers at Albert Einstein College of Medicine in New York and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potentially neutralise the two deadliest strains...
Spider glue research could lead to new materials
Bioscientists at Virginia Tech in the United States have investigated the glue used by orb spiders as part of a project to invent new materials.
The glue – created when glycoproteins are secreted from a...
Team devises way to kill tumour cells
Investigators from Brigham and Women’s Hospital (BWH) and the Harvard Stem Cell Institute in the United States say they may have discovered a way to kill tumour cells that have metastasized to the brain.
The...
Team target resistant infections
Researchers in America have created a new way to identify drugs and drug combinations that may be useful in combating infections that are resistant to many different antibiotics.
Scientists at the National Institutes of Health’s...
Study challenges views on spread of diseases
A study into the way plague spreads through prairie dog colonies in the western United States has yielded insights that could help explain outbreaks of plague, Ebola, and other diseases that can be transmitted...
Study will help treat malaria in pregnant women
A four-year study has shown that four available antimalarial treatments are safe to use in pregnancy.
The PREGACT study (PREGnancy Artemisinin-based Combination Treatments) compared four artemisinin-based combination treatments (ACTs), amodiaquine-artesunate (AQAS), dihydroartemisinin-piperaquine (DHAPQ), artemether-lumefantrine (AL),...
Grants are awarded
Four teams of scientists at Rice University and other Gulf Coast Consortia (GCC) institutions in America have secured research grants from the John S. Dunn Collaborative Research Awards.
GCC member institutions include Baylor College of...
Zika vaccine trial begins
The first of five early stage clinical trials to test the safety and ability of a Zika vaccine candidate has begun in America.
The Zika Purified Inactivated Virus (ZPIV) vaccine, which is designed to generate...
Research leads to ban
Research carried out by a UK-China collaboration played a key role in the introduction of a ban on the use of the antibiotic colistin as a feed additive for animals in China.
The Chinese Ministry...
Development could transform rice production
Two companies have announced a development which could transform life for farmers battling against harsh conditions caused by climate change.
Arcadia Biosciences, an American agricultural technology company, and Asian business Maharashtra Hybrid Seeds Co. Ltd....
Sparking solution to a dental problem
Diamonds could turn out to be a dentist’s best friend, according to research carried out in the United States.
Gold, silver and porcelain are among the many materials dentists can use to fix damaged teeth...
Undiagnosed + untreated = an entirely new approach needed to tackle a growing burden...
The healthcare ‘maths’ of liver-disease diagnosis and treatment simply doesn’t add up, not only in terms of the large and increasing cost to healthcare systems globally, but also – and far more importantly –...
Plant-based solution could ease suffering
A humble plant could offer hope for people at risk of pulmonary hypertension.
Researchers at the University of Pennsylvania (Penn) and the University of Florida in the United States have identified a drug that can...
Grants will further research into Fragile-X
The National Institutes of Health in the United States has awarded more than $35m over the next five years to support research into Fragile-X- associated disorders.
Grants have gone to researchers at three Centers for...